Stay updated on Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The DREAMM-7 study page now displays a 403 Forbidden error, blocking access to the study details and related documents. The previous study content and PDFs listed on the page appear to have been removed or hidden.
    Difference
    19%
    Check dated 2026-09-22T22:00:20.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a publication reference on belantamab pricing in China and updated the page revision from v3.6.6 to v3.7.0.
    Difference
    0.1%
    Check dated 2026-09-15T22:12:52.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.6 and several non-core items (Multiple myeloma, related topics:, MedlinePlus Genetics, Revision: v3.6.5) were removed, indicating a templating or metadata update.
    Difference
    0.1%
    Check dated 2026-09-01T18:02:54.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now includes a 2023 U.S. NIH grant/contract note. Related topic metadata now references MedlinePlus Genetics with the topic 'Multiple myeloma'.
    Difference
    0.1%
    Check dated 2026-08-25T20:39:27.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Removed mentions in the Related topics area: 'Multiple myeloma' and the 'MedlinePlus Genetics' entry (and the 'related topics' header). This reduces disease-specific navigation and external resource links in that section.
    Difference
    0.1%
    Check dated 2026-08-18T19:37:01.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The changes add the core topic 'Multiple myeloma' and include related topics such as 'MedlinePlus Genetics', enhancing the page's topic tagging and navigation. Additionally, the page revision has been updated from v3.6.4 to v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-11T17:18:37.000Z thumbnail image

Stay in the know with updates to Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.